NSRX · Nasus Pharma Ltd · Documents
Market Cap
$38.89M
Shares
11.71M
Volume · Oct 28
4064
Avg daily vol (3M)
17.84K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | On October 8, 2026, Nasus Pharma Ltd. shareholders approved all meeting agenda items by the applicable required majority, except Proposal No. 4; a quorum was present. | 2026-10-08 | — | |
| 6-K | — | 2026-09-18 | — | |
| 6-K | — | 2026-09-14 | — | |
| 6-K | — | 2026-09-04 | — | |
| F-3 | — | 2026-09-01 | — | |
| 6-K | — | 2026-08-19 | — | |
| 6-K | — | 2026-08-17 | 2026-06-30 | |
| 6-K | — | 2026-07-28 | — | |
| 6-K | — | 2026-06-09 | — | |
| 6-K | — | 2026-03-25 | — | |
| 20-F | — | 2026-03-25 | 2025-12-31 | |
| 6-K | — | 2026-03-16 | — | |
| 6-K | — | 2026-03-06 | — | |
| 6-K | — | 2026-03-04 | — | |
| F-1 | — | 2026-03-02 | — | |
| 6-K | — | 2026-02-24 | 2026-02-23 | |
| 6-K | — | 2026-02-13 | — | |
| 6-K | — | 2026-02-12 | 2026-02-11 | |
| 6-K | — | 2026-01-29 | — | |
| 6-K | — | 2026-01-20 | — | |
| 6-K | — | 2025-12-29 | 2025-06-30 | |
| 6-K | — | 2025-12-22 | — | |
| 6-K | — | 2025-11-20 | — | |
| 6-K | — | 2025-11-18 | — | |
| 6-K | — | 2025-11-03 | — | |
| 6-K | — | 2025-10-08 | — | |
| 6-K | — | 2025-09-30 | — | |
| 6-K | — | 2025-09-05 | — | |
| 6-K | — | 2025-08-14 | — | |
| F-1/A | — | 2025-08-07 | — | |
| F-1/A | — | 2025-07-28 | — | |
| F-1 | — | 2025-07-09 | — |
Showing 1–32 of 32 filings